Overactive Bladder - Results from #60

Cost-effectiveness of overactive bladder treatments from a US commercial and payer perspective. January 22, 2023

Real-Time Documentation of the Effect of Onabotulinumtoxin A Detrusor Injection in OAB Patients-Preliminary Results. January 22, 2023

Patients' Preferences and Expectations in Overactive Bladder: A Systematic Review. January 22, 2023

Reduced versus standard intradetrusor OnabotulinumtoxinA injections for treatment of overactive bladder. January 15, 2023

The choice of therapeutic agent in female overactive bladder patients in real-world practice. January 15, 2023

Brain Response Induced by Peroneal Electrical Transcutaneous Neuromodulation Invented for Overactive Bladder Treatment, as Detected by Functional Magnetic Resonance Imaging. January 15, 2023

Prospective, Randomized, Multicenter Trial of Peroneal Electrical Transcutaneous NeuroModulation versus Solifenacin in Treatment of Naïve Patients with Overactive Bladder. January 8, 2023

Sacral neuromodulation for overactive bladder using the InterStim and BetterStim systems. January 8, 2023

Development of an implant technique and early experience using a novel implantable pulse generator with a quadripolar electrode array at the tibial nerve for refractory overactive bladder. January 8, 2023

Prevalence, Risk Factors, and Psychological Effects of Overactive Bladder in Chinese University Students. January 8, 2023

Functional Polymorphism in the ADRB3 Gene, Encoding the Beta-3 Adrenergic Receptor, and Response to Intra-Detrusor Injection of Botulinum Toxin-A in Women with Overactive Bladder. January 1, 2023

Treatment patterns in women with urinary urgency and/or urgency urinary incontinence in the symptoms of Lower Urinary Tract Dysfunction Research Network Observational Cohort Study. January 1, 2023

OnabotulinumtoxinA discontinuation in patients with prior nerve stimulation. January 1, 2023

Evidence-Informed, Interdisciplinary, Multidimensional Action Plan to Advance Overactive Bladder Research and Treatment Initiatives: Directives From State-of-the-Science Conference on Overactive Bladder and Cognitive Impairment. December 25, 2022

Overactive Bladder and Cognitive Impairment: The American Urogynecologic Society and Pelvic Floor Disorders Research Foundation State-of-the-Science Conference Summary Report. December 25, 2022

Overactive Bladder Patients With and Without Urgency Incontinence: A Spectrum of One Condition or Different Phenotypes? December 25, 2022

Predictive factors of de novo overactive bladder in clinically localized prostate cancer patients after robot-assisted radical prostatectomy. December 18, 2022

The Impact of Anticholinergic Use for Overactive Bladder on Cognitive Changes in Adults with Normal Cognition, Mild Cognitive Impairment, or Dementia. December 18, 2022

Unraveling the impact of Lactobacillus spp. and other urinary microorganisms on the efficacy of mirabegron in female patients with overactive bladder. December 11, 2022

CYP2D6 Substrate Dispensing Among Patients Dispensed Mirabegron: An Administrative Claims Analysis. December 11, 2022

Page 4 of 109

SUFU MyBladder app